ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 2805

Synovial Explant Inflammatory Mediator Production Is Associated With Synovitis While Not With Bone Marrow Edema In Rheumatoid Arthritis: A Cross Sectional Study

Martin Andersen1, Mikael Boesen2, Karen Ellegaard1, Robin Christensen3, Kalle Söderström4, Søren Torp-Pedersen1, Bente Danneskiold-Samsøe1, Else Marie Bartels5, Nina Vendel6, Niels H. Søe7, Pieter Spee8, Ulrik GW Mørch9, Lars Karlsson4 and Henning Bliddal10, 1Rheumatology, Copenhagen University Hospital, Bispebjerg and Frederiksberg, The Parker Institute, Department of Rheumatology, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Denmark, Frederiksberg, Denmark, 2Radiology, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Department of Radiology, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Denmark, Frederiskberg, Denmark, 3Department of Rheumatology, Copenhagen University Hospital, Bispebjerg and Frederiksberg, The Parker Institute, Department of Rheumatology, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Denmark, Frederiksberg, Denmark, 4Biopharmaceutical Research Unit, Novo Nordisk, Translational Immunology, Biopharmaceutical Research Unit, Måløv, Novo Nordisk, Denmark, Måløv, Denmark, 5Rheumatology, Copenhagen University Hospital,Bispebjerg and Frederiksberg, The Parker Institute, Department of Rheumatology, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Denmark, Frederiksberg, Denmark, 6Department of Anaesthesiology, Intensive Care and Operations, Gentofte University Hospital, Denmark, Hellerup, Denmark, 7Department of Orthopedics, Section of Hand Surgery, Gentofte University Hospital, Department of Orthopedics, Section of Hand Surgery, Gentofte University Hospital, Denmark, Hellerup, Denmark, 8Biopharmaceutical Research Unit Novo Nordisk, Translational Immunology, Biopharmaceutical Research Unit, Måløv, Novo Nordisk, Denmark, Måløv, Denmark, 9Biomarkers, Søborg, Novo Nordisk, Denmark, Biomarkers, Søborg, Novo Nordisk, Denmark, Søborg, Denmark, 10The Parker Institute, Copenhagen, Denmark

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Biomarkers, Magnetic resonance imaging (MRI), rheumatoid arthritis (RA) and ultrasonography, Synovial Immune Biology

  • Tweet
  • Email
  • Print
Session Information

Session Title: Imaging in Rheumatoid Arthritis

Session Type: Abstract Submissions (ACR)

Background/Purpose: Synovitis and bone damage may represent two distinct but overlapping pathological processes in rheumatoid arthritis (RA). Whereas the bulk of synovial cells contribute to general joint inflammation, the interplay between synovial cells, neighboring cartilage and bony tissue at the margins of the joint contribute to bone degradation(1). The aim of this study was investigate if the levels of inflammatory cytokines interleukine 6 (IL-6), interleukine 8 (IL-8), macrophage chemo-attractant protein 1 (MCP-1) and macrophage inflammatory protein 1 beta (MIP-1b), which all play key roles in RA pathology, correlate with disease intensity and/or can discriminate between key pathological processes in RA.    

Methods: Fifty-seven synovial sites from the hand joints of twenty-five RA patients were evaluated by color Doppler ultrasound (CDUS, 52 synovial sites) and/or high field magnetic resonance imaging (MRI, 39 synovial sites) and subsequently synovectomized by a needle-arthroscopic procedure. Synovial tissue was cultured for 72h, and the concentration of Il-6, Il-8, MCP-1 and MIP-1b in the culture supernatants were measured by Multiplex immunoassays. Ultrasound Doppler was determined as the color fraction. MRI bone marrow edema, synovitis, and erosion score were estimated by the rheumatoid arthritis magnetic resonance score [RAMRIS].  The concentrations of inflammatory mediators were compared to imaging data from the individual sites using repeated samples from the same patients.  Since data was clustered within patients, a mixed linear model was applied for the statistical analysis. Parsimony in the statistical model was achieved omitting covariates with (P>0.1) from the model.

Results: Ultrasound color fraction and the RAMRIS synovitis score were statistically associated with the release of MCP-1 (P=0.004 and P=0.04, respectively), IL-8 (P=0.04 and P=0.04, respectively), and MIP-1b (P=0.01 and P=0.05, respectively), but not with IL-6 (P=0.29 and P=0.21, respectively). IL-6 was the only supernatant mediator, which was associated to the RAMRIS erosion component (P=0.002). There were no statistically significant associations between mediator release and the RAMRIS bone marrow edema component: MCP-1(P=0.07), IL-6 (P=0.93), IL-8 (P=0.40) and MIP-1b (P=0.96).

Conclusion: Levels of IL-8, MCP-1, MIP-1b were significantly associated with clinical assessment of synovitis, but not bone erosion, indicating that these molecules play key roles in general inflammation in the joint, and underlining their potential as biomarkers to measure levels of synovitis. In contrast, levels of IL-6 significantly associted with clinical assessment of bone erosion, indicating that this cytokine, which is known to have direct activating effects on osteoclasts, has potential as a biomarker for measuring bone destructive activity in RA patients.

Acknowledgments: Supported by unrestricted grants from Novo Nordisk, The Danish Agency for Science Technology and Innovation and the Oak Foundation.

References:

(1) Lafeber FP, Van der Laan WH. Progression of joint damage despite control of inflammation in rheumatoid arthritis: a role for cartilage damage driven synovial fibroblast activity. Ann Rheum Dis 2012; 71(6):793-5.


Disclosure:

M. Andersen,

Novo Nordisk,

3;

M. Boesen,
None;

K. Ellegaard,
None;

R. Christensen,

Abbott, Axellus A/S, Bristol-Myers Squibb, Cambridge Weight Plan, Norpharma, Pfizer, and Roche,

5,

Axellus A/S, Cambridge Weight Plan, Mundipharma, and Roche,

2,

Abbott, Axellus, Bayer HealthCare Pharmaceuticals, Biogen Idec, Bristol-Myers Squibb, Cambridge Weight Plan, Ipsen, Laboratoires Expanscience, MSD, Mundipharma, Norpharma, Pfizer, Roche, and Wyeth,

8;

K. Söderström,

Novo Nordisk,

1,

Novo Nordisk,

3;

S. Torp-Pedersen,
None;

B. Danneskiold-Samsøe,
None;

E. M. Bartels,
None;

N. Vendel,
None;

N. H. Søe,
None;

P. Spee,

Novo Nordisk,

1,

Novo Nordisk,

3;

U. G. Mørch,

Novo Nordisk,

1,

Novo Nordisk,

3;

L. Karlsson,

Novo Nordisk,

1,

Novo Nordisk,

3;

H. Bliddal,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/synovial-explant-inflammatory-mediator-production-is-associated-with-synovitis-while-not-with-bone-marrow-edema-in-rheumatoid-arthritis-a-cross-sectional-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences